SG Stock MarketDetailed Quotes

HQXW IX BiopharmaW260718

Watchlist
  • 0.004
  • 0.0000.00%
10min DelayTrading Sep 18 09:18 CST
3.53MMarket Cap0.00P/E (TTM)

IX BiopharmaW260718 Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(Q2)Dec 31, 2019
(Q1)Sep 30, 2019
Operating cash flow (Indirect Method)
Cash from operating activities
-439.47%-8.21M
126.61%2.42M
0.69%-9.08M
-9.15M
-2.54M
-2.47M
Net profit before non-cash adjustment
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
---10.5M
---2.42M
---3.35M
Total adjustment of non-cash items
-75.86%1.86M
1,580.42%7.71M
-147.71%-521K
--1.09M
--56K
--799K
-Depreciation and amortization
-12.36%929K
0.57%1.06M
0.48%1.05M
--1.05M
--260K
--260K
-Reversal of impairment losses recognized in profit and loss
-45.50%103K
8.00%189K
212.50%175K
--56K
----
----
-Assets reserve and write-off
-9.52%19K
-22.22%21K
3.85%27K
--26K
--3K
--6K
-Disposal profit
-153.45%-1.74M
81,575.00%3.26M
-500.00%-4K
--1K
--0
--0
-Net exchange gains and losses
45.53%2.62M
205.44%1.8M
-427.16%-1.71M
---324K
---313K
--518K
-Remuneration paid in stock
-37.94%857K
38.52%1.38M
85.32%997K
--538K
--182K
--102K
-Deferred income tax
-494.50%-1.19M
83.73%-200K
-203.46%-1.23M
---405K
---107K
---110K
-Other non-cash items
30.69%264K
20.96%202K
10.60%167K
--151K
--31K
--23K
Changes in working capital
35.24%-452K
-112.80%-698K
-225.67%-328K
--261K
---178K
--81K
-Change in receivables
-263.95%-848K
-1,394.44%-233K
107.83%18K
---230K
---94K
--112K
-Change in inventory
-359.09%-202K
87.36%-44K
-319.28%-348K
---83K
---6K
--5K
-Change in payables
368.05%713K
-274.65%-266K
-114.00%-71K
--507K
---120K
---156K
-Changes in other current assets
25.81%-115K
-312.33%-155K
8.96%73K
--67K
--42K
--120K
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
-290K
0
-1K
Interest received (cash flow from operating activities)
7K
0
-91.95%7K
87K
22K
27K
Tax refund paid
17.28%828K
-2.62%706K
-1.89%725K
739K
0
742K
Other operating cash inflow (outflow)
0
0
0
0
0
0
Operating cash flow
-345.28%-7.66M
137.39%3.12M
-0.38%-8.35M
---8.32M
---2.52M
---1.7M
Investing cash flow
Net PPE purchase and sale
-247.50%-695K
60.55%-200K
48.48%-507K
---984K
---217K
---181K
Net intangibles purchase and sale
----
----
----
---10K
---10K
----
Net investment product transactions
--0
---5.42M
--0
----
----
----
Investing cash flow
87.64%-695K
-1,009.07%-5.62M
48.99%-507K
---994K
---227K
---181K
Financing cash flow
Net issuance payments of debt
-180.64%-604K
431.42%749K
-6.10%-226K
---213K
---142K
---139K
Net common stock issuance
-71.65%2.73M
-5.53%9.62M
--10.18M
----
----
----
Increase or decrease of lease financing
-3.47%-388K
0.79%-375K
-0.80%-378K
---375K
----
----
Interest paid (cash flow from financing activities)
-34.16%-271K
-16.09%-202K
26.89%-174K
---238K
---57K
---62K
Net other fund-raising expenses
---40K
----
--622K
----
----
----
Financing cash flow
-85.46%1.42M
-2.34%9.79M
1,313.56%10.02M
---826K
---199K
---201K
Net cash flow
Beginning cash position
131.08%12.91M
24.94%5.59M
-69.61%4.47M
--14.71M
--12.58M
--14.71M
Current changes in cash
-195.10%-6.93M
525.67%7.29M
111.49%1.17M
---10.14M
---2.95M
---2.08M
Effect of exchange rate changes
-246.88%-47K
164.00%32K
49.49%-50K
---99K
---13K
---49K
End cash Position
-54.08%5.93M
131.08%12.91M
24.94%5.59M
--4.47M
--9.62M
--12.58M
Free cash flow
-385.84%-8.36M
132.82%2.92M
4.39%-8.91M
---9.31M
---2.75M
---1.88M
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(Q2)Dec 31, 2019(Q1)Sep 30, 2019
Operating cash flow (Indirect Method)
Cash from operating activities -439.47%-8.21M126.61%2.42M0.69%-9.08M-9.15M-2.54M-2.47M
Net profit before non-cash adjustment -109.11%-9.62M44.16%-4.6M21.57%-8.23M---10.5M---2.42M---3.35M
Total adjustment of non-cash items -75.86%1.86M1,580.42%7.71M-147.71%-521K--1.09M--56K--799K
-Depreciation and amortization -12.36%929K0.57%1.06M0.48%1.05M--1.05M--260K--260K
-Reversal of impairment losses recognized in profit and loss -45.50%103K8.00%189K212.50%175K--56K--------
-Assets reserve and write-off -9.52%19K-22.22%21K3.85%27K--26K--3K--6K
-Disposal profit -153.45%-1.74M81,575.00%3.26M-500.00%-4K--1K--0--0
-Net exchange gains and losses 45.53%2.62M205.44%1.8M-427.16%-1.71M---324K---313K--518K
-Remuneration paid in stock -37.94%857K38.52%1.38M85.32%997K--538K--182K--102K
-Deferred income tax -494.50%-1.19M83.73%-200K-203.46%-1.23M---405K---107K---110K
-Other non-cash items 30.69%264K20.96%202K10.60%167K--151K--31K--23K
Changes in working capital 35.24%-452K-112.80%-698K-225.67%-328K--261K---178K--81K
-Change in receivables -263.95%-848K-1,394.44%-233K107.83%18K---230K---94K--112K
-Change in inventory -359.09%-202K87.36%-44K-319.28%-348K---83K---6K--5K
-Change in payables 368.05%713K-274.65%-266K-114.00%-71K--507K---120K---156K
-Changes in other current assets 25.81%-115K-312.33%-155K8.96%73K--67K--42K--120K
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) -290K0-1K
Interest received (cash flow from operating activities) 7K0-91.95%7K87K22K27K
Tax refund paid 17.28%828K-2.62%706K-1.89%725K739K0742K
Other operating cash inflow (outflow) 000000
Operating cash flow -345.28%-7.66M137.39%3.12M-0.38%-8.35M---8.32M---2.52M---1.7M
Investing cash flow
Net PPE purchase and sale -247.50%-695K60.55%-200K48.48%-507K---984K---217K---181K
Net intangibles purchase and sale ---------------10K---10K----
Net investment product transactions --0---5.42M--0------------
Investing cash flow 87.64%-695K-1,009.07%-5.62M48.99%-507K---994K---227K---181K
Financing cash flow
Net issuance payments of debt -180.64%-604K431.42%749K-6.10%-226K---213K---142K---139K
Net common stock issuance -71.65%2.73M-5.53%9.62M--10.18M------------
Increase or decrease of lease financing -3.47%-388K0.79%-375K-0.80%-378K---375K--------
Interest paid (cash flow from financing activities) -34.16%-271K-16.09%-202K26.89%-174K---238K---57K---62K
Net other fund-raising expenses ---40K------622K------------
Financing cash flow -85.46%1.42M-2.34%9.79M1,313.56%10.02M---826K---199K---201K
Net cash flow
Beginning cash position 131.08%12.91M24.94%5.59M-69.61%4.47M--14.71M--12.58M--14.71M
Current changes in cash -195.10%-6.93M525.67%7.29M111.49%1.17M---10.14M---2.95M---2.08M
Effect of exchange rate changes -246.88%-47K164.00%32K49.49%-50K---99K---13K---49K
End cash Position -54.08%5.93M131.08%12.91M24.94%5.59M--4.47M--9.62M--12.58M
Free cash flow -385.84%-8.36M132.82%2.92M4.39%-8.91M---9.31M---2.75M---1.88M
Currency Unit SGDSGDSGDSGDSGDSGD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
SG
Overall
Symbol
Latest Price
% Chg

No Data